IT201900020654A1 - Frazioni di olio di pistacia lentiscus e loro uso nel trattamento o nella prevenzione di infezioni del cavo orale ed otorinolaringoiatriche sostenute da batteri gram-positivi o gram-negativi - Google Patents

Frazioni di olio di pistacia lentiscus e loro uso nel trattamento o nella prevenzione di infezioni del cavo orale ed otorinolaringoiatriche sostenute da batteri gram-positivi o gram-negativi

Info

Publication number
IT201900020654A1
IT201900020654A1 IT102019000020654A IT201900020654A IT201900020654A1 IT 201900020654 A1 IT201900020654 A1 IT 201900020654A1 IT 102019000020654 A IT102019000020654 A IT 102019000020654A IT 201900020654 A IT201900020654 A IT 201900020654A IT 201900020654 A1 IT201900020654 A1 IT 201900020654A1
Authority
IT
Italy
Prior art keywords
gram
ent
infections
fractions
prevention
Prior art date
Application number
IT102019000020654A
Other languages
English (en)
Inventor
Pierro Francesco Di
Original Assignee
Velleja Res S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Velleja Res S R L filed Critical Velleja Res S R L
Priority to IT102019000020654A priority Critical patent/IT201900020654A1/it
Priority to EP20205961.4A priority patent/EP3818987A1/en
Publication of IT201900020654A1 publication Critical patent/IT201900020654A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/22Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT102019000020654A 2019-11-08 2019-11-08 Frazioni di olio di pistacia lentiscus e loro uso nel trattamento o nella prevenzione di infezioni del cavo orale ed otorinolaringoiatriche sostenute da batteri gram-positivi o gram-negativi IT201900020654A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102019000020654A IT201900020654A1 (it) 2019-11-08 2019-11-08 Frazioni di olio di pistacia lentiscus e loro uso nel trattamento o nella prevenzione di infezioni del cavo orale ed otorinolaringoiatriche sostenute da batteri gram-positivi o gram-negativi
EP20205961.4A EP3818987A1 (en) 2019-11-08 2020-11-05 Pistacia lentiscus oil fractions and their use in the treatment or prevention of oral cavity infections and ear, nose and throat infections caused by gram-positive or gram-negative bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000020654A IT201900020654A1 (it) 2019-11-08 2019-11-08 Frazioni di olio di pistacia lentiscus e loro uso nel trattamento o nella prevenzione di infezioni del cavo orale ed otorinolaringoiatriche sostenute da batteri gram-positivi o gram-negativi

Publications (1)

Publication Number Publication Date
IT201900020654A1 true IT201900020654A1 (it) 2021-05-08

Family

ID=69903814

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000020654A IT201900020654A1 (it) 2019-11-08 2019-11-08 Frazioni di olio di pistacia lentiscus e loro uso nel trattamento o nella prevenzione di infezioni del cavo orale ed otorinolaringoiatriche sostenute da batteri gram-positivi o gram-negativi

Country Status (2)

Country Link
EP (1) EP3818987A1 (it)
IT (1) IT201900020654A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112933114A (zh) * 2021-02-08 2021-06-11 吴占强 一种治疗中耳炎的袪痈聪耳油

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
AKSOY A ET AL., ARCH ORAI BIOL., vol. 51, no. 6, June 2006 (2006-06-01), pages 476 - 81
BOZORGI M ET AL., SCIENTIFIC WORLD JOURNAL, vol. 2013, 2013, pages 219815
F. MEZNI ET AL: "In vitro antimicrobial activity of Pistacia lentiscus L. edible oil and phenolic extract", NATURAL PRODUCT RESEARCH, vol. 29, no. 6, 26 August 2014 (2014-08-26), GB, pages 565 - 570, XP055710466, ISSN: 1478-6419, DOI: 10.1080/14786419.2014.952232 *
FATEN MEZNI ET AL: "Evaluation of Pistacia lentiscus seed oil and phenolic compounds for in vitro antiproliferative effects against BHK21 cells", PHARMACEUTICAL BIOLOGY, vol. 54, no. 5, 6 October 2015 (2015-10-06), NL, pages 747 - 751, XP055710648, ISSN: 1388-0209, DOI: 10.3109/13880209.2015.1079222 *
FATEN MEZNI ET AL: "Phenolic profile and effect of growing area on Pistacia lentiscus seed oil", FOOD CHEMISTRY, vol. 257, 1 August 2018 (2018-08-01), NL, pages 206 - 210, XP055710645, ISSN: 0308-8146, DOI: 10.1016/j.foodchem.2018.03.019 *
FLEMMIG TFBEIKLER T, PERIODONTOL 2000, vol. 55, no. 1, February 2011 (2011-02-01), pages 9 - 15
GERMANO ORRÙ ET AL: "The Selective Interaction of Pistacia lentiscus Oil vs. Human Streptococci, an Old Functional Food Revisited with New Tools", FRONTIERS IN MICROBIOLOGY, vol. 8, 24 October 2017 (2017-10-24), XP055710468, DOI: 10.3389/fmicb.2017.02067 *
LIU W ET AL., ZHONGGUO ZHONG YAO ZHI., vol. 44, no. 17, pages 3684 - 3694
MEZNI F ET AL., NAT PROD RES., vol. 29, no. 6, 2015, pages 565 - 70
ORUP G, FRONT MICROBIOL., vol. 8, 24 October 2017 (2017-10-24), pages 2067
PARASCHOS S ET AL., CURR MED CHEM., vol. 19, no. 14, 2012, pages 2292 - 302
POGALNY SIMONOVA M ET AL., RES VET SCI., vol. 88, no. 2, April 2010 (2010-04-01), pages 203 - 7
REID G., CURR INFECT DIS REP., vol. 2, no. 6, December 2000 (2000-12-01), pages 518 - 522
VERKAIK MJ ET AL., J DENT., vol. 39, no. 3, March 2011 (2011-03-01), pages 218 - 24
VIEIRA COLOMBO AP ET AL., MICROB PATHOG., vol. 94, May 2016 (2016-05-01), pages 27 - 34

Also Published As

Publication number Publication date
EP3818987A1 (en) 2021-05-12

Similar Documents

Publication Publication Date Title
CY1125136T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1123196T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1122344T1 (el) Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων
CO2017013446A2 (es) Composiciones que comprenden cepas bacterianas del género bacteroides
MD3313421T2 (ro) Compoziții cuprinzând o tulpină bacteriană de Blautia hydrogenotrophica pentru utilizare în tratamentul infecțiilor bacteriene ale tractului gastrointestinal
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
CL2018003425A1 (es) Composiciones de cannabidiol y usos de las mismas.
BR112021017950A2 (pt) Bactéria da família christensenellaceae para prevenção e/ou tratamento de doenças inflamatórias crônicas e/ou doenças inflamatórias gastrointestinais e/ou cânceres
WO2017017631A3 (en) Antibacterial therapeutics and prophylactics
CU20160187A7 (es) (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobencil)carbamoil)-2,3,4,5,7,9,13, 13a-octahidro-2,5-metanopirido[1',2':4,5]pirazino[2,1-b][1,3]oxazepin-8-olato de sodio
BR112015030389A2 (pt) uso de i) uma fonte de proteína, ii) um prebiótico e iii) um probiótico para a fabricação de uma composição nutricional para o tratamento ou a prevenção de infecção em um indivíduo alérgico
WO2015003816A3 (en) Cystobactamides
NZ724798A (en) Polymyxin derivatives as antimicrobial compounds
BR112015029367A2 (pt) terapia combinada compreendendo oxazolidinona-quinolonas para uso no tratamento de infecções bacterianas
EP3860619A4 (en) COMPOSITIONS AND METHODS FOR TREATING PATHOGENIC INFECTIONS IN PLANTS
ZA202002093B (en) Antibacterial compounds
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
PH12018500358A1 (en) Compounds for use in an antibacterial applications
ZA201907487B (en) Compositions and treatment procedures for the treatment of pathogenic infections
IT201900020654A1 (it) Frazioni di olio di pistacia lentiscus e loro uso nel trattamento o nella prevenzione di infezioni del cavo orale ed otorinolaringoiatriche sostenute da batteri gram-positivi o gram-negativi
IL281770A (en) History of indan for the treatment of bacterial infection
IL275796A (en) Bacteriophage compositions for treating pseudomonas infections